Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | RBM19 |
| Upstream (Parents) |
|---|
| (<<) KIAA1199 → RBM19 |
| (<<) TRAF5 → RBM19 |
| (<<) IGF1R → RBM19 |
| (<<) NEK11 → RBM19 |
| (<<) WDR60 → RBM19 |
| Downstream (Children) |
|---|
| RBM19 → PLA2G4B///JMJD7///JMJD7-PLA2G4B (>>) |
| RBM19 → SOX13 (>>) |
| RBM19 → MSMB (>>) |
| RBM19 → LRP1B (>>) |
| RBM19 → IKZF3 (>>) |
| RBM19 → CHD7 (>>) |
| RBM19 → RRAD (>>) |
| RBM19 → HABP4 (>>) |
| RBM19 → LTB4R (>>) |
| RBM19 → NCR1 (>>) |
| RBM19 → HOXD9 (>>) |
| RBM19 → AGTPBP1 (>>) |
| RBM19 → MOS (>>) |
| RBM19 → OR10H3 (>>) |
| RBM19 → C17orf86 (>>) |
| RBM19 → OR1F1 (>>) |
| RBM19 → LOC728683///LOC442421 (>>) |
| RBM19 → NEK11 (>>) |
| RBM19 → HDAC5 (>>) |
| RBM19 → KIAA1009 (>>) |
| RBM19 → NYNRIN (>>) |
